Skip to main content Skip to main navigation menu Skip to site footer

Absolute Neutrophil Count as Predictor Hematopoietic Recovery in Acute Lymphoblastic Leukemia in Remission Induction Phase Chemotherapy

  • pdf  |
  • Published: 2022-04-30

Abstract

Introduction: The main treatment for leukemia is chemotherapy therapy, divided into the induction of remission, consolidation, and maintenance therapy. Early response to remission-induced therapy is an important prognostic factor in ALL. This study aimed to assess the relationship between absolute neutrophil count (ANC) and bone marrow improvement after undergoing induction phase chemotherapy which was characterized by the occurrence of remission.

Methods: Acute Lymphoblastic Leukemia diagnosed based on CBC, peripheral smear, bone marrow morphology, and flow cytometry. Nineteen samples from children with Acute Lymphoblastic Leukemia were evaluated for blast count and absolute neutrophil count (ANC) on day 0, ANC on 3rd week, and blast count and ANC on the 6th week of remission induction therapy. We compared the results of outcomes after remission induction therapy.

Results: The ANC value at the 3rd week and 6th week of the chemotherapy phase was positively correlated with remission with the r=0.687 and with a p-value=0.001.

Conclusion: The trend of increasing ANC values ​​was moderately positively correlated with the incidence of remission.

References

  1. Kiem Hao T, Nhu Hiep P, Kim Hoa NT, Van Ha C. Causes of Death in Childhood Acute Lymphoblastic Leukemia at Hue Central Hospital for 10 Years (2008-2018). Glob Pediatr Heal. 2020;7.
  2. Health Research and Development Agency. Basic Health Research. Natl Rep 2013. 2013;1–384.
  3. Tarigan ADT, Ariawati K, Widnyana P. Prevalensi dan karakteristik anak dengan leukemia limfoblastik akut tahun 2011-2015 di RSUP Sanglah Denpasar. Medicina (B Aires). 2019;50(2):391–5. doi:10.15562/Medicina.v50i2.287
  4. Tampubolon PC, Lubis B, Aman AK, Nasution MR. Immunophenotyping Pattern in Childhood Acute Leukemia in the Adam Malik Hospital Medan. Indones J Clin Pathol Med Lab. 2020;27(1):1–6. doi: http://dx.doi.org/10.24293/ijcpml.v27i1.1602
  5. Rauf SE, Khan SA, Ali N, Afridi NK, Haroon M, Arslan A. Remisyon ındüksiyon kemoterapisi alan akut lenfoblastik lösemi hastalarında hematopoietik toparlanmanın öngörülmesinde ımmatür retikülosit fraksiyonu ve mutlak nötrofil sayısı. Turkish J Hematol. 2016;33(2):131–4. doi: 10.4274/tjh.2014.0379
  6. Martinez MF, Alveal E, Soto TG, Bustamante EI, Ávila F, Bangdiwala SI, et al. Il-6 −572c > g and card8 304t>a genetic polymorphisms are associated with the absolute neutrophil count in patients with hematological malignancies under chemotherapy: An application of multilevel models to a preliminary pharmacogenetic study. Pharmgenomics Pers Med. 2020;13:337–43. doi: https://doi.org/10.2147/PGPM.S261208
  7. Vyas D, Laput G, Vyas AK. Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis. Onco Targets Ther. 2014;7:1015–23. doi: 10.2147/OTT.S60114.
  8. Chiba Y, Mizoguchi I, Hasegawa H, Ohashi M, Orii N, Nagai T, et al. Regulation of myelopoiesis by proinflammatory cytokines in infectious diseases. Cell Mol Life Sci [Internet]. 2018;75(8):1363–76. Available from: https://doi.org/10.1007/s00018-017-2724-5
  9. Hijiya N, Onciu M, Howard SC, Zhang Z, Cheng C, Sandlund JT, et al. Utility of automated counting to determine absolute neutrophil counts and absolute phagocyte counts for pediatric cancer treatment protocols. Cancer. 2004;101(11):2681–6. doi: 10.1002/cncr.20677.
  10. Lehrnbecher T, Robinson P, Fisher B, Alexander S, Ammann RA, Beauchemin M, et al. Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update. J Clin Oncol. 2017;35(18):2082–94. doi: 10.1200/JCO.2016.71.7017.
  11. Taplitz RA, Kennedy EB, Bow EJ, Crews J, Gleason C, Hawley DK, et al. Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical practice guideline update. J Clin Oncol. 2018;36(14):1443–53. doi: 10.1200/JCO.2017.77.6211.
  12. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. blood J. 2017;127(20):453–62. doi: 10.1016/J.Tvjl.2015.01.019.
  13. Brown P, Inaba H, Annesley C, Beck J, Colace S, Dallas M, et al. Pediatric acute lymphoblastic leukemia, version 2.2020. JNCCN J Natl Compr Cancer Netw. 2020;18(1):81–112. doi: 10.6004/jnccn.2020.0001.
  14. Perdani R, Sudarmanto B. Hematological parameters and remission induction of childhood acute lymphoblastic leukemia. PI [Internet]. 30Apr.2018 [cited 28Jan.2022];58(2):71. doi: https://doi.org/10.14238/pi58.2.2018.71-4
  15. Shawahna R, Mosleh S, Odeh Y, Halawa R, Al-Ghoul M. Clinical characteristics and outcomes of patients with pediatric acute lymphoblastic leukemia after induction of chemotherapy: a pilot descriptive correlational study from Palestine. BMC Res Notes [Internet]. 2021;14(1):1–8. doi: https://doi.org/10.1186/s13104-021-05678-6
  16. Özdemir N, Tüysüz G, Çelik N, Yantri L, Erginöz E, Apak H, et al. Febrile neutropenia in children with acute lymphoblastic leukemia: Single center experience. Turk Pediatr Ars. 2016;51(2):79–86. doi: 10.5152/TurkPediatriArs.2016.2757
  17. Kong, SG et al. Childhood acute lymphoblastic leukemia with hyperleukocytosis at presentation. Blood Research. 2014; 29-35. doi: 10.5045/br.2014.49.1.29
  18. Bhojwani D, Howard SC, Pui CH. High-risk childhood acute lymphoblastic leukemia. Clin Lymphoma Myeloma [Internet]. 2009;9 Suppl 3(September):S222–30. doi: http://dx.doi.org/10.3816/CLM.2009.s.016
  19. Rabin KR. Management Strategies in Acute Lymphoblastic Leukemia [Internet]. 2011. ONCOLOGY, 25(4). Retrieved from https://www.cancernetwork.com/view/management-strategies-acute-lymphoblastic-leukemia
  20. Schiffer CA, Connor RF. Hyperleucocitosis and leukostasis in hematologic malignances. UpToDate [Internet]. 2016;1–9. Available from: www.uptodate.com
  21. Wilson NR, Khan M, Cox TM, Nassif M, Qiao W, Garg N, et al. Bleeding outcomes in thrombocytopenic acute leukemic patients with venous thromboembolism. eJHaem. 2020;1(2):448–56. doi: https://doi.org/10.1002/jha2.90
  22. Stevens M, Frobisher C, Hawkins M, Jenney M, Lancashire E, Reulen R, et al. The British Childhood Cancer Survivor Study: Objectives, methods, population structure, response rates and initial descriptive information. Pediatr Blood Cancer. 2008;50(May):1018–25. doi: 10.1002/pbc.21335.
  23. Bakhshi S, Padmanjali KS, Arya LS. Infections in childhood acute lymphoblastic leukemia: An analysis of 222 febrile neutropenic episodes. Pediatr Hematol Oncol. 2008;25(5):385–92. doi: 10.1080/08880010802106564.
  24. O’Connor D, Bate J, Wade R, Clack R, Dhir S, Hough R, et al. Infection-related mortality in children with acute lymphoblastic leukemia: An analysis of infectious deaths on UKALL2003. Blood. 2014;124(7):1056–61. doi: 10.1182/blood-2014-03-560847

How to Cite

Nasution, M. R., Putri Chadijah Tampubolon, & Irma Sari Nasution. (2022). Absolute Neutrophil Count as Predictor Hematopoietic Recovery in Acute Lymphoblastic Leukemia in Remission Induction Phase Chemotherapy. Bali Medical Journal, 11(1), 471–475. Retrieved from https://balimedicaljournal.org/index.php/bmj/article/view/3185

HTML
0

Total
0

Share

Search Panel

Malayana Rahmita Nasution
Google Scholar
Pubmed
BMJ Journal


Putri Chadijah Tampubolon
Google Scholar
Pubmed
BMJ Journal


Irma Sari Nasution
Google Scholar
Pubmed
BMJ Journal